Skip to main content
Patients Referrer
 
Book Online Call Now Modify Booking
Image
https://www.qscan.com.au/wp-content/uploads/2015/04/10-Dr-James-FitzGerald2.jpg

Dr James
Fitzgerald

MBBS, FRANZCR
Specialties and interests
  • MRI
  • Interventional radiology
  • Spinal imaging
  • Musculoskeletal imaging
  • Sports medicine imaging
About

Dr James Fitzgerald is a radiologist at Qscan Radiology Clinics. He graduated from the University of Queensland in 1988 and completed his postgraduate training in radiology at the Royal Brisbane and Women's Hospital. 

James' patients include athletes from many sports and major sporting teams across Australia. James liaises closely with sports specialists and uses cutting-edge technology and procedures to provide patients with the best possible outcome.

Fellowships
  • Diagnostic and Interventional Neuroradiology, The University of Rochester Medical Centre, New York in 2000-2002
Other positions
  • Interventional radiologist, Royal Brisbane Hospital
  • Lectures at a national and international level
  • Teaching students, trainees and other specialists

News & Articles

 

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.